Michael Bernard Ohanessian brings extensive experience gained from technology-related businesses with a mixture of operational, strategic and leadership capabilities. Following a ten-year career at Mobil Oil, Michael joined the Boston Consulting Group where he consulted to clients in a wide range of industries which include banking, airlines, mining, packaging, sports, oil and gas, retailing and biotechnology.
Michael became the CEO of Vision BioSystems (now Leica BioSystems) where he led a transformation over seven years into a globally successful medical diagnostics company. He has also served as CEO and Managing Director of ASX-listed Genetic Technologies Limited and has been involved in investment management and corporate advice with Lion Capital. Michael then joined ASX-listed Praemium Limited as its CEO and Managing Director from 2011 to 2021. Michael was a Non-Executive Director of the SGP Group of Companies (now Trajan) and has been a Non-Executive Director of ASX-listed Bluechiip since 2014.

Raoul’s extensive experience and IT knowledge saw him work as a consultant for some of the most important companies in Italy and abroad: the Italian Automobile Club (ACI), Publitalia’80 (Mediaset Group) and other top International Motorsport Federations. Raoul has been involved with Haemokinesis since 2014, where he was in charge of software development. He joined the company in 2018 as COO and implemented software and instrument production improvements.

In more than 25 years, Raoul has mastered many different technologies, particularly focused on the development of complex and functional product management architectures. His passion for streamlining industry and processes led him to become a certified Six Sigma Black Belt and to gain certification in Scrum Agile project management.

Siobhan joined Haemokinesis in 2012 as Production Manager soon after Haemokinesis was established. Siobhan has over 16 years’ experience in the Immunohaemolatology Industry starting her career with Dia-Med Australia before moving on to Lateral Grifols. She moved from Ireland to Australia in 2004 after completing a 4 years honours degree in Bachelor of Science, majoring in Industrial Microbiology from University College Dublin (UCD).

During her career she has worked on research, design, production and regulatory adherence of diagnostic reagents. Siobhan has brought her knowledge and skill into the Haemokinesis portfolio and is committed to compliant and high-quality products.

Sanjeev joined Haemokinesis in April 2021. Sanjeev has substantial experience in the immunohaematology and clinical diagnostics sector, joining us from Bio-Rad Laboratories. Sanjeev was previously the Regional Manager (South Pacific Region), Clinical Diagnostics Group at Bio-Rad and prior to that was the Regional Marketing Manager (Asia-Pacific) at Thermo Fisher Scientific.

Sanjeev has more than 17 years of experience in the Life Science and Clinical diagnostic markets. Furthermore, he has significant experience in establishing distributors and large-scale distributor networks. Sanjeev holds a PhD (Biological Sciences) from the University of Sydney along with an Executive MBA from the Australian Catholic University. He is also a member of the Australian Institute of Company directors.

Natasha joined Haemokinesis in 2017 as Production Validation Specialist after completing her PhD (Chemical Engineering) as part of a collaboration between Monash University and Haemokinesis. Prior to that, she had 3 years of Immunohaematology experience working as a Production Scientist in the Production and QC department of Grifols Australia. In her 6 years with Haemokinesis, she has been involved in product research and development, product validation and registration, and the management of the QC team.